Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for ...
Microsoft’s cross-platform .NET takes interesting dependencies, including a fork of Google’s Skia, now to be co-maintained with Uno Platform.
What if AI-assisted development is less of a threat, and more of a jetpack? This month’s report tackles vibe coding, along ...
Hosted on MSN
JP Morgan Upgrades Replimune Group (REPL)
Fintel reports that on October 20, 2025, JP Morgan upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underweight to Neutral. Analyst Price Forecast Suggests 18.55% Downside As of ...
Heather Hill with her husband Randy at the Daytime Emmy Awards in 1996. Heather Hill, the six-time Emmy Award-winning director who directed hundreds of episodes of “The Young and the Restless,” died ...
Warner Bros. Discovery is smack in the eye of the latest media M&A maelstrom — and staffers are bracing for the possibility that they’ll get a new corporate overlord in the near future. The leading ...
Get the latest updated list of insiders for Replimune Group, Inc. (REPL). Find out the total of insider shares held, purchased and sold.
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback